Normal View Dyslexic View

Pembrolizumab versus placebo as adjuvant therapy in completely resected stage IIB or IIC melanoma (KEYNOTE-716): a randomised, double-blind, phase 3 trial.

17 May 2022
Randomized clinical trials General

Info
Copied!